Sign In
Buy AVAI
$0.130
+0.0035 (+2.79%)
At Close: Aug 04, 2026
Avant Brands Announces Timing of Release of Fiscal 2025 Annual Results
04:30pm, Monday, 23'rd Feb 2026
KELOWNA, BC / ACCESS Newswire / February 23, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website
08:43am, Wednesday, 11'th Feb 2026
LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes a
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
01:31pm, Thursday, 29'th Jan 2026
/PRNewswire/ -- USA News Group News Commentary - Global capital is officially rotating into "Longevity Infrastructure" which is now valued at a massive $27
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
08:30am, Monday, 26'th Jan 2026
LAS VEGAS, Jan. 26, 2026 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes a
Avant Brands Adopts Shareholder Rights Plan
04:30pm, Friday, 09'th Jan 2026
KELOWNA, BC / ACCESS Newswire / January 9, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products,
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
08:15am, Tuesday, 16'th Dec 2025
LAS VEGAS , Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes a
LAS VEGAS , Dec. 9, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes
LAS VEGAS--(BUSINESS WIRE)--Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-r
THE CRITICAL LIST: 5 Stocks Anchoring the New Economy
09:12am, Monday, 08'th Dec 2025
Issued on behalf of Quantum Security Encryption Corp. VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- USANewsGroup .com Market Intelligence Brief – The market is in triage. Speculativ
Avant Brands Fully Repays $9.5M Secured Convertible Debenture
07:30am, Monday, 08'th Dec 2025
KELOWNA, BC / ACCESS Newswire / December 8, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products,
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
08:00am, Tuesday, 18'th Nov 2025
LAS VEGAS--(BUSINESS WIRE)--Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-
LAS VEGAS , Oct. 21, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company") and global biotechnology firm, Austrianova, today announced the official launch of their join
Avant Brands Announces Results for Q3 2025
04:30pm, Wednesday, 15'th Oct 2025
KELOWNA, BC / ACCESS Newswire / October 15, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products,
Avant Brands Recognized as One of Canada's Top Growing Companies by The Globe and Mail for Third Consecutive Year
07:30am, Monday, 29'th Sep 2025
KELOWNA, B.C. / ACCESS Newswire / September 29, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis produ
Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies
08:00am, Thursday, 25'th Sep 2025
LAS VEGAS , Sept. 25, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), today announced a pivotal evolution in its business direction, emphasizing strategic partn
